SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Nov-13 5:27 PM View: | Allergan Plc (AGN) | 04-Nov-13 | Market Sale | 7,200 | $156.71 | $1,128,330.00 | (3770%) (-0.19) to 7.01K | (7%) |
02-Oct-13 8:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 14,209 | -- | -- | (100%) 14.21K to 0 | |
03-Oct-13 4:19 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 14,209 | -- | -- | 100% 0 to 14.21K | |
02-Oct-13 8:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 11,952 | -- | -- | 81% 14.7K to 26.65K | |
02-Oct-13 8:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 15,291 | $144.00 | $2,201,900.00 | (52%) 29.5K to 14.21K | 83% |
02-Oct-13 8:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Option Exercise | 2,851 | -- | -- | 11% 26.65K to 29.5K | |
08-Mar-13 5:56 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 6,018 | -- | -- | 69% 8.68K to 14.7K | |
02-Nov-12 12:36 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Oct-12 | Grant | 2,909 | -- | -- | 50% 5.77K to 8.68K |